publicaciones seleccionadas artículo académico A highly efficient tumor-infiltrating MDSC differentiation system for discovery of anti-neoplastic targets, which circumvents the need for tumor establishment in mice. Oncotarget. 5:7843-7857. 2014 Assessing T-cell responses in anticancer immunotherapy: Dendritic cells or myeloid-derived suppressor cells?. Journal of OncoImmunology. 2:e26148. 2013 Immune modulation by genetic modification of dendritic cells with lentiviral vectors. Virus Research. 176:1-15. 2013 PD-L1 co-stimulation, ligand-induced TCR down-modulation and anti-tumor immunotherapy. Oncoimmunology. 1:86-88. 2012 On the Mechanism of T cell receptor down-modulation and its physiological significance. The Journal of Bioscience and Medicine. 1:1-5. 2011 Selective Activation of Intracellular Signalling Pathways In Dendritic Cells For Cancer Immunotherapy. Anti-cancer Agents in Medicinal Chemistry. 12:29-39. 2011
